# ZNF500

## Overview
ZNF500 is a gene that encodes the zinc finger protein 500, a member of the zinc finger protein family known for its role in transcriptional regulation. The protein functions primarily as a transcriptional repressor, utilizing its SCAN domain to interact with various co-repressors and proteins, thereby influencing gene expression (Itokawa2009KAP1independent). ZNF500 is involved in the regulation of RNA polymerase II transcription, which is essential for mRNA synthesis in eukaryotic cells (Zhang2024Differentially). In cancer research, ZNF500 has been noted for its potential tumor suppressor role, particularly in breast cancer, where it stabilizes the P53 protein (Zhang2024Differentially). Despite its emerging significance in cancer biology, the full spectrum of ZNF500's functions in normal cellular processes and its clinical implications remain areas of active investigation.

## Function
ZNF500, a member of the zinc finger protein family, functions primarily as a transcriptional repressor. It is involved in transcriptional regulation through its interaction with various co-repressors and proteins, such as DHX9, hnRNPU, and NCL, which suggests alternative pathways for its activity independent of KAP1 (Itokawa2009KAP1independent). The protein's transcriptional repression activity is largely attributed to its SCAN domain, which is essential for its function, as demonstrated by the ability of GAL4DBD-SCAN/KRAB domains to repress transcription (Itokawa2009KAP1independent).

ZNF500 is also implicated in the regulation of RNA polymerase II transcription, which is crucial for the synthesis of mRNA in eukaryotic cells (Zhang2024Differentially). In the context of cancer, ZNF500 has been identified as a protein that can suppress breast cancer cell proliferation by stabilizing the tumor suppressor protein P53, thereby competing with MDM2 (Zhang2024Differentially). This function highlights its potential role in maintaining cellular homeostasis and preventing uncontrolled cell growth. Despite its involvement in cancer, specific details about ZNF500's function in healthy human cells remain limited.

## Clinical Significance
The clinical significance of the ZNF500 gene is not well-established, but some studies have explored its potential involvement in various conditions. A variant in the ZNF500 gene, c.461G>A, p.(Gly154Glu), was identified in patients with ovarian hyperstimulation syndrome (OHSS). This variant is considered a single nucleotide polymorphism (SNP) rather than a pathogenic mutation, and no direct association with OHSS or other known diseases was found (Stouffs2018Rare).

In cancer research, ZNF500 has been studied for its expression patterns. In breast and prostate cancer cell lines, ZNF500 showed a lack of expression due to homozygous deletions, suggesting that alterations in its expression or gene organization could be significant in cancer contexts (Yamamoto2006Scanning). Additionally, ZNF500 was identified as a candidate gene potentially involved in the pathogenesis of familial non-medullary thyroid cancer (FNMTC), although specific details on its role remain unclear (Jiang2024Chromosomal).

Overall, while ZNF500 has been implicated in some genetic and cancer studies, its precise clinical significance and role in disease pathogenesis require further investigation.


## References


[1. (Jiang2024Chromosomal) Yu-jia Jiang, Yun Xia, Zhuo-jun Han, Yi-xuan Hu, and Tao Huang. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer. Frontiers in Oncology, March 2024. URL: http://dx.doi.org/10.3389/fonc.2024.1286426, doi:10.3389/fonc.2024.1286426. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2024.1286426)

[2. (Itokawa2009KAP1independent) Yasuhide Itokawa, Toshihide Yanagawa, Hisashi Yamakawa, Naoko Watanabe, Hisashi Koga, and Takahiro Nagase. Kap1-independent transcriptional repression of scan-krab-containing zinc finger proteins. Biochemical and Biophysical Research Communications, 388(4):689–694, October 2009. URL: http://dx.doi.org/10.1016/j.bbrc.2009.08.065, doi:10.1016/j.bbrc.2009.08.065. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.08.065)

[3. (Yamamoto2006Scanning) Miyako Yamamoto, Ray Hyungjoo Ahn, and Fumiichiro Yamamoto. Scanning copy number and gene expression on the 16p13.3‐13.2 chromosomal region by the systematic multiplex polymerase chain reaction and reverse transcription‐polymerase chain reaction methods. ELECTROPHORESIS, 27(13):2529–2540, June 2006. URL: http://dx.doi.org/10.1002/elps.200500875, doi:10.1002/elps.200500875. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/elps.200500875)

[4. (Zhang2024Differentially) Zihan Zhang, Lei Fu, Bei Yun, Xu Wang, Xiaoxi Wang, Yifan Wu, Junjie Lv, Lina Chen, and Wan Li. Differentially localized protein identification for breast cancer based on deep learning in immunohistochemical images. Communications Biology, August 2024. URL: http://dx.doi.org/10.1038/s42003-024-06548-0, doi:10.1038/s42003-024-06548-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-024-06548-0)

[5. (Stouffs2018Rare) Katrien Stouffs, Sari Daelemans, Samuel Santos-Ribeiro, Sara Seneca, Alexander Gheldof, Ali Sami Gürbüz, Michel De Vos, Herman Tournaye, and Christophe Blockeel. Rare genetic variants potentially involved in ovarian hyperstimulation syndrome. Journal of Assisted Reproduction and Genetics, 36(3):491–497, November 2018. URL: http://dx.doi.org/10.1007/s10815-018-1372-5, doi:10.1007/s10815-018-1372-5. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10815-018-1372-5)